About SIA
Surgical Innovation Associates, Inc. (“SIA”, sia.health) is a commercial stage medical device company, committed to raising the standard of care in plastic, reconstructive, and general surgery and lowering systemic costs through “for surgeon, by surgeon” medical device innovation. Headquartered in downtown Chicago, Illinois, SIA’s proximity to academia and world-leading healthcare institutions has created the ideal ecosystem for the translation of concepts into devices to meet key clinical needs.
The company’s flagship product family, DuraSorb® Monofilament Mesh is on the market and indicated for use in reinforcement of soft tissues where weakness exists. DuraSorb® was specifically designed for plastic, reconstructive, and general surgery and is US FDA 510(k) cleared and CE marked. The product is available in multiple sizes, and is part of a growing pipeline of novel medical devices made from commonly-used resorbable polymers.
|
|
|
1,001-5,000 employees
View all SIA employees
|
|
Biotechnology
|
|
445 W Erie St, Chicago, Illinois 60654, US
|
|
2016
|
SIA Alternatives
Frequently Asked Questions about SIA
Arvids Zarins is the CEO of SIA. To contact Arvids Zarins email at [email protected] or [email protected].
The decision makers in SIA are Andre Fredericks, Andre Cacador, Bashir Chaudhary, etc. Click to Find SIA decision makers emails.
SIA Staff Directory
Search SIA Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.
